Skip to main content

Pharma News

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Guduchi is safe and does not produce any toxic effects says, Ayush Ministry

    Certain sections of the media have falsely linked again Giloy/Guduchi to liver damage. The Ministry of Ayush reiterates that Giloy/Gudduchi (Tinospora cordifolia) is safe and as per available data, Guduchi does not produce any toxic effect.

  • CSIR-CDRI Nucleic Acid Staining Dye technology licensed

    Lucknow based national laboratory CSIR-Central Drug Research Institute (CDRI), has licensed the technology of Nucleic Acid Staining Dye GreenR to GenetoProtein Pvt. Ltd., a start-up company registered in Uttar Pradesh in the year 2020. This startup is involved in developing an array of enzymes, kits and biochemical used in Lifesciences research, particularly molecular biology. The dye GreenR™ has been developed by CDRI Senior Principal Scientist Dr. Atul Goel in a joint collaborative project with an industry partner Biotech Desk Pvt. Ltd., Hyderabad.

  • Lupin Pharmaceuticals gets USFDA Approval for SOLOSEC

    Lupin Pharmaceuticals Inc announced that the U.S. Food and Drug Administration has approved the company s supplemental New Drug Application (sNDA) to expand the use of SOLOSEC® (secnidazole) in the treatment of bacterial vaginosis (BV) for female patients 12 years of age and older and in the treatment of trichomoniasis for all patients 12 years of age and older.

  • Breakthrough, US woman got cured from HIV by stem cell transplant

    A U.S. patient with leukemia has become the first woman and the third person to date to be cured of HIV after receiving a stem cell transplant from a donor who was naturally resistant to the virus that causes AIDS, researchers reported.

    The oral abstract was presented at CROI 2022, the Conference on Retroviruses and Opportunistic Infections.

  • Novartis India to lay off 400 employees

    Novartis India has entered into an exclusive sales and distribution agreement with Dr. Reddys Laboratories for a few of its established medicines and it led to lay off 400 employees due to role redundancies.

  • Heart attack survivors may be less likely to develop Parkinsons disease

    People who have had a heart attack may be slightly less likely than people in the general population to develop Parkinsons disease later in life, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

  • Unexpected findings detailed in new portrait of HIV

    Using powerful tools and techniques developed in the field of structural biology, researchers at the University of Washington and Scripps Research have discovered new details about the human immunodeficiency virus, HIV. The findings bring into focus the basic architecture of the virus just above and below its surface and may help in the design and development of a vaccine that can protect against AIDS.

  • When to use or not use Antibiotics on your Skin

    Cold weather can be hard on your skin. When your skin becomes dry, as often happens in the winter, it can easily crack and bleed. When caring for a cut or other wound, it might seem logical to apply an antibiotic cream or ointment from the store to fight off germs and prevent infection. However, these antibiotic creams and ointments can irritate your skin even more and cause a painful and/or itchy rash, called contact dermatitis.

  • Revive Therapeutics Receives FDA Orphan Drug Designation for Bucillamine

    Revive Therapeutics Ltd a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the U.S. Food and Drug Administratio has granted Orphan Drug Designation for Bucillamine for the prevention of ischemia–reperfusion injury during liver transplantation.

  • A new multipurpose on-off switch for inhibiting bacterial growth

    Researchers in Lund have discovered an antitoxin mechanism that seems to be able to neutralise hundreds of different toxins and may protect bacteria against virus attacks. The mechanism has been named Panacea, after the Greek goddess of medicine whose name has become synonymous with universal cure. The understanding of bacterial toxin and antitoxin mechanisms will be crucial for the future success of so-called phage therapy for the treatment of antibiotic resistance infections, the researchers say. The study has been published in PNAS.

Subscribe to Pharma News